AKT1 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), DMAMCL triggers apoptosis and induces cell cycle arrest at the G2/M phase by activating reactive oxygen species (ROS) production and inhibiting the PI3K/Akt pathway (Yao et al., 2020).